Every patient deserves protection from disabling stroke
Safeguard quality of life for Transcatheter Aortic Valve Replacement (TAVR) patients in just four minutes2 per procedure. New data from the PROTECTED TAVR Study showed SENTINEL™ Cerebral Protection System (CPS) reduced the risk of disabling, perioperative stroke by 60% through 72-hours.1
The PROTECTED TAVR Study
PROTECTED TAVR Results
The primary endpoint did not meet statistical significance, but the data demonstrated a numerical trend towards a lower rate of stroke in patients treated with the SENTINEL device, representing a 21% relative risk reduction in all stroke through 72-hours or time of hospital discharge.
A secondary analysis demonstrated a statistically significant 60% relative risk reduction in disabling stroke through 72-hours or time of hospital discharge in patients treated with the SENTINEL device.